Christina Herder, Idogen acting CEO
With cash running low, Swedish cell therapy company looks to sell off platform
Small cell therapy company Idogen will have to liquidate the company if another solution isn’t found soon, like a reverse merger or the sale of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
